Humana (HUM) stock fell by 4.44% last night, as analysts suggest that Select Medical is a more favorable investment option due to its stronger consensus rating, higher potential upside, and lower valuation metrics compared to Humana.

Humana (HUM) stock fell by 4

Humana (HUM) stock fell 4.44% due to ongoing legal issues stemming from a class action lawsuit that alleges the company misled investors about its earnings and failed to disclose rising medical costs and increased utilization rates associated with pent-up demand for healthcare services.

Humana (HUM) stock fell 4

Humana's stock rose 12.4% after the company reported stronger-than-expected results for the spring and raised its forecasts for annual profit and revenue.

Humana's stock rose 12

Humana (HUM) stock rose 10.3% after the company reported stronger-than-expected quarterly results and raised its profit and revenue forecasts for the year. 

The increase in Humana's stock price is attributed to its solid financial performance and optimistic outlook, which exceeded market expectations.

Humana (HUM) stock rose 10

Humana (HUM) shares rose by 12.4% after the health insurer raised its guidance and reported better-than-expected results, indicating a smaller decline in Medicare Advantage membership than previously anticipated.

Humana (HUM) shares rose by 12

Humana (HUM) stock rose 12.4% due to strong market reactions following various positive economic indicators, including a narrower-than-expected trade deficit that boosted GDP estimates, along with positive corporate earnings forecasts contributing to overall investor confidence.

Humana (HUM) stock rose 12

Humana (HUM) stock rose by 12.4% following positive analyst recommendations and a strong institutional ownership indicating confidence in its long-term performance, alongside a favorable comparison of its financial metrics against Aethlon Medical.

Humana (HUM) stock rose by 12

The article discusses the decline in UnitedHealth Group's (UNH) stock after it reported second-quarter earnings that beat revenue expectations but missed on earnings per share, while Humana (HUM) stock rose by 0.48% likely due to investor confidence in Humana's operational strategies and management responding proactively to industry challenges, such as reducing prior authorizations for patient care.

The article discusses the decline in UnitedHealth Group's (UNH) stock after it reported second-quart

Humana (NYSE:HUM) stock rose 0.48% as investors are optimistic about the company's upcoming earnings report, following a recent quarter where it met revenue expectations despite losing customers. 

The stock's increase is likely due to analysts' expectations for continued revenue growth, Humana's historical record of exceeding earnings expectations, and overall stability among health insurance providers before earnings are announced.

Humana (NYSE:HUM) stock rose 0

Humana (HUM) stock increased by 0.48% as analysts anticipate strong quarterly earnings results, with projected earnings surpassing previous estimates, attracting positive analyst ratings and significant institutional investment. The rise is likely due to optimistic earnings expectations and favorable analyst upgrades.

Humana (HUM) stock increased by 0

Humana (HUM) stock experienced a 0.48% increase likely due to investor confidence following UnitedHealth Group's earnings, despite its struggle with high costs and operational challenges, signaling potential market resilience in health insurance amidst broader industry concerns.

Humana (HUM) stock experienced a 0

Humana (HUM) stock fell by 2.71% after Robert W. Baird cut its price objective from $300.00 to $297.00, maintaining a neutral rating on the insurance provider, amidst mixed analyst reports regarding the company's stock.

Humana (HUM) stock fell by 2

Humana (HUM) stock rose 3.83% last night due to an overall positive earnings season for companies, with many S&P 500 firms exceeding earnings expectations amidst lowered analyst forecasts, which likely boosted investor confidence in the stock.

Humana (HUM) stock rose 3

Humana (HUM) stock rose 3.83% as part of a broader positive trend in the stock market amid a favorable second quarter earnings season, where a significant number of companies reported better-than-expected earnings, boosting investor sentiment.

Humana Inc. (NYSE:HUM) stock declined by 3.34% amid a consensus "Hold" recommendation from analysts, despite positive quarterly earnings, possibly affected by broader market conditions or investor concerns.

Humana Inc

Humana Inc. (HUM) stock fell by 3.34% due to various institutional investors adjusting their positions, market volatility, and mixed analyst ratings despite the company reporting strong quarterly earnings.

Humana (HUM) stock was up 3.44% due to positive investor sentiment stemming from increased holdings in the healthcare sector, particularly as investors focus on the potential recovery and operational improvements in companies like UnitedHealth Group, which is closely watched by hedge funds.

Humana (HUM) stock was up 3

Humana (HUM) stock fell by 1.4% due to sector-wide declines influenced by an analyst downgrade and a negative legal outcome related to Medicare bonus payments, alongside broader market concerns regarding rising costs and inadequate pricing for health insurers' 2025 plans.

Humana (HUM) stock fell by 1

Humana Inc. (HUM) shares saw a decline of 1.33% recently, amid mixed perspectives from analysts and increased selling pressure from institutional investors. The stock's drop can be attributed to a downgrade in sentiment from some research analysts, notably Wall Street Zen's shift from a "buy" to a "hold" rating, which may have influenced investor confidence negatively.

Humana (NYSE:HUM) stock rose 2.1% after the company reported strong quarterly earnings that exceeded analysts' expectations and received positive upgrades from several equity research firms. The increase in stock price can be attributed to the firm’s impressive earnings report, which included a significant earnings per share increase, an 8.4% revenue growth year-over-year, and favorable analyst ratings suggesting potential for further price appreciation.

Humana (NYSE:HUM) stock rose 2

Humana Inc. (NYSE:HUM) stock rose 2.1% as a result of several positive factors, including a strong earnings report beating analyst expectations, favorable price target adjustments from analysts, and significant interest from institutional investors.

Humana (HUM) stock fell by 1.39% after being downgraded from a "buy" to a "hold" rating by Wall Street Zen, despite some positive ratings from other analysts.

Humana (HUM) stock declined by 0.65% as several institutional investors adjusted their stakes amidst mixed analyst ratings, which likely contributed to market uncertainty regarding the stock's valuation.

Humana (HUM) stock declined by 0

Humana Inc. (HUM) stock saw a slight increase of 0.12% following a reduction in holdings by Principal Financial Group and various institutional investors adjusting their stakes, combined with the company's strong quarterly earnings report that exceeded analyst expectations and the announcement of a quarterly dividend. The stock's rise can be attributed to positive earnings performance, investor confidence from institutional buying activity, and favorable market interest in its stock amidst ongoing changes in hedge fund positions.

Humana Inc. (NYSE:HUM) shares fell by 1.69% after the company reported stronger-than-expected earnings, reflecting a mixed market sentiment despite an increase in earnings per share estimates from analysts. The decline could be attributed to profit-taking and market volatility rather than negative fundamentals, as the company continues to show growth.

Humana (HUM) stock saw a decline of 1.69% last night, which may be attributed to broader market fluctuations or negative sentiment surrounding the health insurance sector as indicated by various investment analysts and market ratings.

Humana (HUM) stock saw a decline of 1

Humana (HUM) stock increased by 1.07% due to a combination of strong quarterly earnings that surpassed expectations, positive analyst ratings, as well as increased institutional investor interest despite some adjustments to price targets.

Humana (HUM) stock increased by 1

Humana Inc. (HUM) stock rose 0.83% last night, likely due to positive quarterly earnings results that exceeded analysts' expectations, a recent dividend announcement, and a significant percentage of ownership by institutional investors, indicating strong market confidence in the company.

Humana Inc. (NYSE:HUM) stock rose by 0.83% due to significant increases in institutional investments and positive earnings results, along with favorable analyst price targets and a recent dividend announcement.

Humana Inc. (HUM) stock rose by 0.83% due to a favorable earnings report that surpassed analysts' expectations and increasing institutional ownership, alongside a recently announced dividend.

Humana (HUM) stock increased by 1.76% as a result of significant investments and stake adjustments by institutional investors, along with strong quarterly earnings that surpassed analysts' expectations.

Humana (HUM) stock fell by 2.07% as a result of adjustments in analyst price targets and general market sentiment, with several firms rating the stock as "neutral," indicating cautious investor outlooks.

Humana (HUM) stock fell by 1.55% after Mission Wealth Management LP reduced its holdings in the company, alongside a trend of analyst downgrades and lowered price targets from multiple firms, indicating concerns about the stock's performance.

Humana (HUM) stock rose by 0.81% following the assignment of a $280.00 price target by Truist Financial analysts, which suggests a potential upside from its current price, alongside recent positive earnings that exceeded expectations. The increase in Humana's stock value can be attributed to favorable analyst ratings and strong quarterly earnings results, reflecting investor confidence in the company's performance.

Humana (HUM) stock rose by 0

Humana (NYSE:HUM) stock saw a slight increase of 0.13% following various analysts' ratings and price target adjustments, despite Barclays lowering its target price from $273.00 to $268.00. The stock's performance may be attributed to its recent quarterly earnings beat, increased dividends, and institutional investor interest as several large investors have significantly raised their stakes in the company.

Humana (NYSE:HUM) stock saw a slight increase of 0

Humana (HUM) stock rose 0.13% due to significant institutional interest, as UMB Bank n.a. increased its holdings by nearly 100%, along with other large investors, which reflects confidence in the company's strong earnings report and dividend offerings.

Humana (HUM) stock rose 0

Humana Inc. (HUM) stock rose by 1.39% following positive earnings reports that surpassed analyst estimates and a new price target estimate from Cantor Fitzgerald, which suggests a favorable outlook despite a "Neutral" rating.

Humana (HUM) stock fell by 0.47%, potentially due to broader market pressures reflecting ongoing financial challenges in the healthcare sector, including reported layoffs and financial strains impacting other healthcare organizations like Virginia Mason Franciscan Health.

Humana (HUM) stock fell by 0

Humana (HUM) stock rose 1.56% last night amidst an ongoing investigation into potential violations of federal securities laws, which may have led investors to buy on perceived value or recovery potential following a lawsuit related to alleged illegal kickbacks.

Humana (HUM) stock rose 1

The article discusses an investigation by Edelson Lechtzin LLP into potential federal securities law violations involving SelectQuote, which includes allegations of receiving kickbacks from Humana for Medicare Advantage plan enrollments. Humana's stock rose by 1.56% due to overall market sentiment or confidence in the company's operations despite the allegations affecting SelectQuote.

The article discusses an investigation by Edelson Lechtzin LLP into potential federal securities law

Humana Inc. (HUM) stock decreased by 1.11%, with a consensus recommendation of "Hold" from analysts and several recent price target reductions reflecting cautious sentiment, which may have contributed to the decline in its stock price.

Humana (HUM) stock dropped by 1.11% after Barclays lowered its target price for the company from $322.00 to $273.00, indicating potential concerns about the stock’s valuation amidst recent fluctuations in analyst ratings.

Headline	Summary	Source
Humana (HUM) stock fell by 4	Humana (HUM) stock fell by 4.44% last night, as analysts suggest that Select Medical is a more favorable investment option due to its stronger consensus rating, higher potential upside, and lower valuation metrics compared to Humana.	ETF Daily News
Humana (HUM) stock fell 4	Humana (HUM) stock fell 4.44% due to ongoing legal issues stemming from a class action lawsuit that alleges the company misled investors about its earnings and failed to disclose rising medical costs and increased utilization rates associated with pent-up demand for healthcare services.	Globenewswire

HUM

Latest News & Analysis